earnings
NASDAQ · KPTI
Karyopharm Therapeutics Inc.
Healthcare · Biotechnology
$2.03
Down-$0.04 (-1.85%)
Updated Aug 13, 2026, 7:41 PM
SID Score
2.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 59.5M
- P/E ratio
- -0.48
- Dividend yield
- 0.00%
- 52-week range
- $1.80 – $10.86
- Volume
- 1.84M
- Avg. volume
- 181.65K
Price performance
KPTI price history
1M range · 21 trading sessions · Daily adjusted prices
KPTI closed at $2.03 after 21 trading sessions, down 78.70% for the selected period.
- Last close
- $2.03
- Period change
- -78.70%
- Period low
- $1.91
- Period high
- $9.53
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 12, 2026 | $2.10 | $2.1491 | $2.00 | $2.03 | 1.84M |
| Aug 11, 2026 | $1.93 | $2.18 | $1.93 | $2.10 | 1.96M |
| Aug 10, 2026 | $2.14 | $2.1786 | $1.915 | $1.96 | 1.8M |
| Aug 7, 2026 | $1.96 | $2.12 | $1.91 | $2.12 | 1.79M |
| Aug 6, 2026 | $1.88 | $2.005 | $1.88 | $1.95 | 1.19M |
| Aug 5, 2026 | $1.94 | $2.055 | $1.88 | $1.91 | 2.38M |
| Aug 4, 2026 | $2.00 | $2.11 | $1.94 | $1.96 | 3.79M |
| Aug 3, 2026 | $1.94 | $2.05 | $1.80 | $1.97 | 4.51M |
| Jul 31, 2026 | $2.19 | $2.43 | $1.80 | $1.92 | 22.4M |
| Jul 30, 2026 | $6.98 | $7.09 | $6.555 | $7.01 | 4.54M |
| Jul 29, 2026 | $7.04 | $7.47 | $6.73 | $6.86 | 436.89K |
| Jul 28, 2026 | $7.10 | $7.14 | $6.75 | $7.09 | 531.29K |
| Jul 27, 2026 | $7.45 | $7.84 | $7.015 | $7.09 | 527.47K |
| Jul 24, 2026 | $7.15 | $7.605 | $6.992 | $7.41 | 900.25K |
| Jul 23, 2026 | $7.14 | $7.19 | $6.75 | $7.09 | 680.13K |
| Jul 22, 2026 | $7.92 | $8.02 | $7.05 | $7.18 | 713.64K |
| Jul 21, 2026 | $7.49 | $8.27 | $7.46 | $7.865 | 943.08K |
| Jul 20, 2026 | $9.40 | $9.45 | $6.485 | $7.47 | 2.33M |
| Jul 17, 2026 | $9.35 | $9.59 | $9.31 | $9.51 | 205.24K |
| Jul 16, 2026 | $9.55 | $9.84 | $9.36 | $9.38 | 236.38K |
| Jul 15, 2026 | $9.85 | $9.86 | $9.38 | $9.53 | 316.49K |
Latest KPTI news
The latest Smart Investors Daily articles mentioning KPTI.
Stock researchResearch & News · SEC Filings
Loading stock research…